Drug recall · January 9, 2013
Synthroid recall
Why: Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.
- Lots / codes
LOT # 18262A8 Exp. 09/13
- Quantity
- 28, 524 bottles
- Company
- Abbott Laboratories, Abbott Park, IL
- Distribution
- US Nationwide and Puerto Rico
- Initiated
- December 4, 2012 · Voluntary: Firm initiated
- Classified
- December 28, 2012
- Reported
- January 9, 2013
- Ended
- July 10, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Synthroid
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.